#URU URU Metals Limited – Final Results
URU Metals is pleased to announce its final results for the year ended 31 March 2025. The full Report & Accounts are available on the Company’s website and are expected to be posted to shareholders today. To view the full Report & Accounts with the illustrative figures and tables please use the following link: https://www.rns-pdf.londonstockexchange.com/rns/3824B_1-2025-9-30.pdf […]
#FCM First Class Metals PLC – Suspension of Listing
First Class Metals PLC (“First Class Metals” “FCM” or the “Company”) the UK listed metals exploration company seeking economic metal discoveries across its extensive Canadian, focused in northern Ontario, land holdings, would like to provide an update regarding the delay to the publication of its consolidated audited results for the financial year ended 31 December […]
#FCM First Class Metals – Sunbeam: Update of exploration activities
First Class Metals PLC (“First Class Metals” “FCM” or the “Company”) the UK metals exploration company seeking large scale metal discoveries across its extensive Canadian Schreiber-Hemlo Sunbeam and Zigzag land holding is pleased to provide an update on the Sunbeam past producing high grade gold mine. Highlights · Initial results from the Roy prospect have […]
#SVML Sovereign Metals LTD – Annual Report 2023, Issue of Shares and AGM Date
ANNUAL REPORT FOR THE FINANCIAL YEAR ENDED – 30 JUNE 2023 Sovereign Metals Limited (“Sovereign” or the “Company”) (ASX:SVM, AIM:SVML) advises that its 2023 Annual Report, has been published today at https://sovereignmetals.com.au/company-reports/ and as below. The Company also advises that an Appendix 4G (Key to Disclosures: Corporate Governance Council Principles and Recommendations) and 2023 […]
ECR Minerals #ECR – Half-year Report
UNAUDITED HALF-YEARLY RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2023 AND UPDATE LONDON: 30 JUNE 2023 – ECR Minerals plc, the gold exploration and development company, is pleased to announce unaudited interim results for the six months ended 31 March 2023, along with a review of significant developments during and post period. HIGHLIGHTS Although somewhat […]
#SVML Sovereign Metals – Half-year Report
SOVEREIGN METALS LIMITED ABN 71 120 833 427 INTERIM FINANCIAL REPORT FOR THE HALF YEAR ENDED 31 DECEMBER 2022 CORPORATE DIRECTORY Directors Mr Benjamin Stoikovich Chairman Dr Julian Stephens Managing Director Mr Ian Middlemas Non-Executive Director Mr Mark Pearce Non-Executive Director Mr Nigel Jones Non-Executive Director Company Secretary Mr Dylan Browne […]
#SVML Sovereign Metals Limited- Result of AGM
The Annual General Meeting (AGM) of Sovereign Metals Limited (Company) (ASX:SVM, AIM:SVML) was held today, 18 November 2022, at 10.00am (AWST). The resolutions voted on were in accordance with the Notice of AGM previously advised to the Australian Securities Exchange and shareholders. All resolutions were decided on and carried by way of poll. In accordance […]
#ORPH Open Orphan – PLC Notice of results
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that it will release its interim results for the six months ended 30 June 2022 on 8 September 2022. Investor presentation Yamin ‘Mo’ Khan, Chief […]
#POW Power Metal Resources – Disposal of Reitenbach Uranium Property – Canada
Power Metal Resources plc (LON:POW), the London listed exploration company seeking large-scale metal discoveries across its global project portfolio announces the conditional disposal of its 100% owned Reitenbach Uranium Property (“Reitenbach” or the “Property”) located east of the prolific Athabasca Basin in Northern Saskatchewan, Canada. HIGHLIGHTS: – A Property Purchase Agreement (the “Agreement”) has been signed […]
Open Orphan #ORPH – Final results Reveal Record revenues and EBITDA-profitability accompanied by significant operational progress
Open Orphan (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces its audited final results for the 12 months ended 31 December 2021. Financial highlights · Record revenues of £39.0m (2020: £22.2m) achieved representing 76% growth · […]